• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Voyager Therapeutics, Inc. - Common Stock (NQ:VYGR)

5.320 +0.340 (+6.83%)
Streaming Delayed Price Updated: 2:13 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Voyager Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 30, 2025
 
Via Benzinga
Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst
September 15, 2025
Voyager's Alzheimer's programs show longer CNS exposure and potential gene therapy advances, with analysts maintaining a Buy rating and $30 price target. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 09, 2025
 
Via Benzinga
7 Analysts Assess Voyager Therapeutics: What You Need To Know
April 08, 2025
 
Via Benzinga
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts
March 12, 2025
 
Via Benzinga
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 5 Analysts
December 02, 2024
 
Via Benzinga
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
November 14, 2024
 
Via Benzinga
Earnings Scheduled For March 11, 2025
March 11, 2025
 
Via Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
 
Via Benzinga
Preview: Voyager Therapeutics's Earnings
November 11, 2024
 
Via Benzinga
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics
October 16, 2024
 
Via Benzinga
What Analysts Are Saying About Voyager Therapeutics Stock
July 31, 2024
 
Via Benzinga
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
April 17, 2024
Should you consider VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) for growth investing? 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 22, 2024
 
Via Benzinga
Get “Picky” With Stocks For September Profits
September 09, 2024
Via Talk Markets
3 High-Growth Stocks Poised To Double By Next Year
August 28, 2024
The article outlines three high-growth stocks that could double by 2025, using specific screening criteria: strong buy ratings from multiple analysts, significant revenue and earnings growth, and... 
Via Talk Markets
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks. 
Via InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
VYGR stock results show that Voyager Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Is NASDAQ:VYGR a Fit for Growth Investing Strategies?
March 27, 2024
High growth, ROE and relative strength for VOYAGER THERAPEUTICS INC (NASDAQ:VYGR), growth investors may appreciate this. 
Via Chartmill
Delving into NASDAQ:VYGR's Growth Prospects.
March 26, 2024
Why VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) qualifies as a high growth stock. 
Via Chartmill
Exploring NASDAQ:VYGR's growth characteristics.
March 05, 2024
VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 13, 2024
VYGR stock results show that Voyager Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
March 27, 2024
With a possible rotation away from the technology space, these are the undervalued healthcare stocks to consider. 
Via InvestorPlace
Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20
March 21, 2024
With so many thousands of securities available, there are bound to be compelling ideas for value stocks under $20. 
Via InvestorPlace
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
March 19, 2024
Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising CNS-targeted gene therapies and strategic partnerships driving long-term... 
Via Benzinga
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
March 05, 2024
Unlocking the Growth Potential of VOYAGER THERAPEUTICS INC (NASDAQ:VYGR). 
Via Chartmill
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
February 29, 2024
Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps. 
Via Benzinga
Topics Economy Stocks
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
February 29, 2024
Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 29, 2024
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 28, 2024
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Recent Quotes
View More
Symbol Price Change (%)
GOOG  250.22
+4.03 (1.64%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap